DOI QR코드

DOI QR Code

뇌내출혈로 입원치료 받던 중 만성B형간염 면역관용기에서 면역활동기로 전환된 환자에 대한 생간탕가감 치험 1례

A Case Report of the Efficacy of Saenggan-tang-gagam in the Treatment of a Patient with Chronic Hepatitis B Who Showed Conversion of the Immune-Tolerant Phase to Immune-Clearance Phase during Hospitalization for Intracerebral Hemorrhage

  • 배정한 (경희대학교 대학원 임상한의학과) ;
  • 김하연 (경희대학교 대학원 임상한의학과) ;
  • 주성희 (경희대학교 대학원 임상한의학과) ;
  • 장은경 (경희대학교 대학원 임상한의학과) ;
  • 이장훈 (경희대학교 대학원 임상한의학과) ;
  • 김영철 (경희대학교 대학원 임상한의학과)
  • Bae, Jung-han (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Ha-yeon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Joo, Seong-hee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Jang, Eun-gyeong (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Lee, Jang-hoon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Kim, Young-chul (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 투고 : 2017.03.24
  • 심사 : 2017.05.26
  • 발행 : 2017.05.30

초록

Objectives: The purpose of this case report is to describe the efficacy of Saenggan-tang-gagam treatment in a patient with immune-tolerant chronic hepatitis B who converted to the immune active phase during hospitalization for Intracerebral hemorrhage. Methods: A 61-year-old male patient with chronic hepatitis B was hospitalized from July 21, 2016 to October 24, 2016. On September 5, the patient showed fatigue and dyspepsia, and his urine was dark. These symptoms were accompanied by a dramatic elevation of aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and gamma-glutamyl transferase (GGT) levels. Saenggan-tang-gagam was administered three times a day until the patient was discharged from the hospital. Results: After the Saenggan-tang-gagam treatment, AST and ALP levels decreased significantly, below the upper limit level. In addition, the levels of ALT and GG were significantly decreased. In addition, the fatigue, dyspepsia, and dark urine induced by hepatitis improved after the Saenggan-tang-gagam treatment. Conclusion: This case report suggests that traditional Korean medicine has a beneficial effect on the immune active phase of chronic hepatitis B.

키워드

참고문헌

  1. Park CH, Lee SM, Kim TO, Kim DU, Jung WJ, Kim GH, et al. Treatment of solitary extramedullary plasmacytoma of the stomach with endoscopic submucosal dissection. Gut Liver 2009;3:334-7. https://doi.org/10.5009/gnl.2009.3.4.334
  2. Ministry of Helalth & Welfare KCfDCaP. The Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV), 2010. Health Examination. Ministry of Helalth & Welfare 2012.
  3. Chae HB, Kim JH, Kim JK, Yim HJ. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009;15(Suppl 6):S13-S24. https://doi.org/10.3350/kjhep.2009.15.S6.S13
  4. Cheon JH, Park JW, Park KW, Kim YI, Kim SH, Lee WJ, et al. The clinical report of 1,078 cases of hepatocellular carcinomas: National Cancer Center experience. Korean J Hepatol 2004;10:288-97.
  5. Bae SH, Yoon SK, Jang JW, Kim CW, Nam SW, Choi JY, et al. Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea. J Korean Med Sci 2005;20:816-20. https://doi.org/10.3346/jkms.2005.20.5.816
  6. Kim H, Jee YM, Song BC, Shin JW, Yang SH, Mun HS, et al. Molecular epidemiology of hepatitis B virus (HBV) genotypes and serotypes in patients with chronic HBV infection in Korea. Intervirology 2007;50:52-7. https://doi.org/10.1159/000096313
  7. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-39. https://doi.org/10.1002/hep.21513
  8. Tran TT. Immune tolerant hepatitis B: a clinical dilemma. Gastroenterol Hepatol (NY) 2011;7:511-6.
  9. Lee PI, Chang MH, Lee CY, Hsu HY, Chen JS, Chen PJ, et al. Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children. Hepatology 1990;12(4 Pt 1):657-60. https://doi.org/10.1002/hep.1840120406
  10. Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia-Pacific region. Core Working Party for Asia-Pacific Consensus on Hepatitis B and C. J Gastroenterol Hepatol 2000;15:825-41. https://doi.org/10.1046/j.1440-1746.2000.02324.x
  11. Chu CJ, Hussain M, Lok AS. Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection. Hepatology 2002;36 :1408-15. https://doi.org/10.1002/hep.1840360617
  12. Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology 2009;50:661-2. https://doi.org/10.1002/hep.23190
  13. Woo HJ, Kim BW, Kim DH. Clinical study on differentiation of syndromes of various liver diseases and SGOT/SGPT Ratio. J Korean Med 1986;7(2):61-9.
  14. Choi SY, Kim BW. Studies on the Effect of Saengkantang on liver protection, platelet aggregation and general immune-function. College of Oriental Medicine, Kyung Hee Univ Oriental Med J 1987;10:25-57.
  15. Seung HS, Park SM, Han CW, Kim YC, Lee JH, Woo HJ. Two cases of Hepatitis Treated with Gagamsaenggan-tang. Korean J Orient Int Med 2002;23(2):229-37.
  16. Korea Centers for Disease Control and Prevention. 2006 Disease Control White Paper. Korea Centers for Disease Control and Prevention 2007:144.
  17. Kim BW, Kim JJ. Studies on the Effect of Saengkankunbi-tang on the Metabolism and Regenerative Function in Liver(Biochemical and Electromicroscopic Studies). Kyung Hee Univ Oriental Med J 1982;5(1):19-40.
  18. Hong MS. Experimental Studies on the Efficacy of Saenggan-tang. A master's thesis. College of Oriental Medicine, Kyung Hee University 1987.
  19. Kim DH, Shim JO, Hong MS, Woo HJ, Kim BW. Clinical Observation of Liver Disease Patients. The journal of KOMS 1987;8(2):14-23.
  20. Shin YS, Cho SH, Kim NU, Han YH. Clinical Report of Acute Cholecystitis with Gagamsaenggantang. Korean J Oriental Physiology & Pathology 2009;23(6):1465-9.
  21. Yoon SH, Lew JH, Jang MS. Response of Kagamseanggantang on the Liver Function in Alcoholic Liver Diseases. KOMS 1993;14(2):348-54.
  22. Ha YD. Antitumoral, Antioxidant and Antimicrobial Activities of Solvent Ftactions from Grifola umbllatus. The Journal of Korean Society of Food Preservation 2001;8(4):481-7.
  23. Oh YH, Lee UY, Lee MW, Him MJ, Lee TS. Immuno-modulatory and Antitumor Effect of Crude Polysaccharides Extracted from Sclerotium of Grifola umbellata. The Korean J of Mycology 2004;32(1):23-30. https://doi.org/10.4489/KJM.2004.32.1.023